Results 71 to 80 of about 76,872 (109)

HIV-1 Genetic Diversity and Transmitted Drug Resistance Mutations in ART-Naïve Individuals in South Korea from 2021 to 2024. [PDF]

Viruses
Kim G, Kim EJ, Kim MS, Kim S, Kim HM, Han MG, Wang JS.   +6 more
europepmc   +1 more source

Increase in HIV-1-transmitted drug resistance among ART-naïve youths at the China-Myanmar border during 2009 ~ 2017. [PDF]

BMC Infect Dis, 2021
Ding Y, Chen M, Wang J, Yang Y, Feng Y, Wang L, Duan S, Lin Q, Xing H, Ma Y, Han M, Ma L.   +11 more
europepmc   +1 more source

Prevalence and Molecular Epidemiology of Transmitted Drug Resistance and Genetic Transmission Networks Among Newly Diagnosed People Living With HIV/AIDS in a Minority Area, China. [PDF]

Front Public Health, 2021
Yuan D, Yu B, Li Y, Wang Z, Liu M, Ye L, Huang Y, Su L, Zhang Y, Api L, Chen M, Zhou C, Liu L, Zhang L, Liang S, Jia P, Yang S.   +16 more
europepmc   +1 more source

Prevalence of Doravirine Resistance Mutations in a Large-Scale HIV-1 Transmitted Drug Resistance Survey in Buenos Aires, Argentina. [PDF]

Viruses
Cecchini D, Cassetti I, Scarnato F, Fiori A, Nuevo J, Villaverde C, Sucari A, Torroija MC, Bissio E, Bugarin G, Lopardo G.   +10 more
europepmc   +1 more source

Transmitted drug resistance to Tenofovir/Emtricitabine among persons with newly diagnosed HIV infection in Shenyang city, Northeast China from 2016 to 2018. [PDF]

BMC Infect Dis, 2021
Wang Z, Zhao B, An M, Song W, Dong X, Li X, Wang L, Wang L, Tian W, Ding H, Han X.   +10 more
europepmc   +1 more source

Characteristics of molecular epidemiology and transmitted drug resistance among newly diagnosed HIV-1 infections in Lishui, China from 2020 to 2023. [PDF]

Virol J
Li J, Mei J, Yu J, Chen X, Zhu J, Ye J, Zhang D, Cheng D, Chen X.   +8 more
europepmc   +1 more source

HIV-1 transmitted drug resistance in newly diagnosed individuals in Italy over the period 2015-21. [PDF]

J Antimicrob Chemother
Fabeni L, Armenia D, Abbate I, Gagliardini R, Mazzotta V, Bertoli A, Gennari W, Forbici F, Berno G, Piermatteo L, Borghi V, Pinnetti C, Vergori A, Mondi A, Parruti G, Di Sora F, Iannetta M, Lichtner M, Latini A, Mussini C, Sarmati L, Perno CF, Girardi E, Antinori A, Ceccherini-Silberstein F, Maggi F, Santoro MM, Italian HIV Drug Resistance Group.   +27 more
europepmc   +1 more source

Transmitted drug resistance and molecular transmission network among treatment-naive HIV-1 patients in Wenzhou, China, 2020-2023. [PDF]

Virol J
Zhang T, Dou H, Ye H, Tang H, Wang W, Hu W, Lv B, Zhou M, Dai H, Wang W, Sun B.   +10 more
europepmc   +1 more source

HIV-1 transmitted drug resistance surveillance: shifting trends in study design and prevalence estimates. [PDF]

J Int AIDS Soc, 2020
Rhee SY, Kassaye SG, Barrow G, Sundaramurthi JC, Jordan MR, Shafer RW.   +5 more
europepmc   +1 more source

Prevalence of transmitted drug resistance and phylogenetic analysis of HIV-1 among antiretroviral therapy-naïve patients in Northern Vietnam from 2019 to 2022. [PDF]

Glob Health Med
Tran GV, Hayashida T, Dang AL, Nagai M, Matsumoto S, Tran LK, Le HN, Van TD, Tanuma J, Pham TN, Oka S.   +10 more
europepmc   +1 more source